Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine + Tranexamic Acid in Knee Arthroplasty
NCT07089251Phase 4Recruiting
- Sponsor
- King Abdullah International Medical Research Center
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of epinephrine in osteoarthritis (OA) (2 arms), sponsored by King Abdullah International Medical Research Center. Primary endpoint: Perioperative blood loss. Started Jul 2025; status: recruiting.
02
Drugs
epinephrine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07089251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07089251.